At ACM Biolabs we are focused on developing novel vaccines and antibodies using our proprietary artificial cell membrane ("ACM") technology. We are able to incorporate functional, folded membrane proteins into the artificial cell membranes which keep them stable, allowing them to induce a strong immune reaction. We have demonstrated efficacy via both injected and oral dosages using synthesized membrane proteins and have a growing pipeline of vaccine and antibodies. Our customers use our technology to develop drugs against hard membrane targets..
Logo 8
Logo 7
Logo 6
Logo 5
Logo 4
Logo 3
Logo 1
Emerging Enterprise Award

Contact Us


Send Us a Message



ACM Biolabs Pte Ltd.

18 Nanyang Drive
Innovation Center
Blk 2, Unit no: 124B
Singapore 637723